Loading chat...
NJ A277
Bill
Status
Passed
11/8/2021
Primary Sponsor
John Armato
Click for details
AI Summary
Legislative Description
Requires public members of Drug Utilization Review Board to disclose financial interests and benefits received from and investment interests held in pharmaceutical distributors, pharmaceutical manufacturers, or pharmacy benefits managers.
Bills and Joint Resolutions Signed by the Governor
Last Action
Approved P.L.2021, c.285.
11/8/2021
Committee Referrals
Health, Human Services and Senior Citizens8/3/2020
Health1/14/2020
Full Bill Text
No bill text available